324.20
+1.12%
Close of 9 Nov 2026, in SEK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Bonesupport Holding
Its shares trade on Nasdaq Stockholm under the ticker BONEX.ST. It has been listed since 21 June 2017. In the fiscal year to 31 December 2025, it reported revenue of SEK 1.17bn and net income of SEK 142.2m. At that date it held total assets of SEK 1.04bn and shareholders' equity of SEK 867.3m.
BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. The company is headquartered in Lund, Skane. The company went IPO on 2017-06-21. The company develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 21 Jun 2017
- Employees
- 86
- Website
- bonesupport.com ↗
Leadership
Pay as last reported
- Mr. Lennart JohanssonIndependent Chairman of the BoardSEK 2.5m
- Mr. Emil BillbaeckChief Executive OfficerSEK 18.5m
- Mr. Torbjoern SkoeldChief Executive Officer
- Mr. Hakan JohanssonChief Financial OfficerSEK 256,000
- Mr. Fergus MacleodGeneral Manager, Executive Vice President - Commercial Operations EUROW
- Mr. Michael RothGeneral Manager, Executive Vice President - Commercial Operations North America
- Mrs. Annelie ViknerExecutive Vice President - Global Marketing
- Ms. Helena BrandtExecutive Vice President of Human Resources
- Dr. Michael DiefenbeckExecutive Vice President - Medical and Clinical Affairs, Chief Medical Officer
- Mr. Michael MortensenExecutive Vice President - Research and Development, Operations
- Ms. Anna StegmarkExecutive Vice President - Quality Management & Regulatory Affairs
- Dr. Bjoern OdlanderDirectorSEK 335,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 38
- Environment
- 42
- Social
- 29
- Governance
- 42
- Women in the workforce
- 54.33071%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Bonesupport Holding AB possesses several strengths that contribute to its success:
Weaknesses
- Despite its strengths, Bonesupport Holding AB faces certain weaknesses that may pose challenges:
Opportunities
- Bonesupport Holding AB has opportunities for growth and expansion:
Threats
- Bonesupport Holding AB faces certain threats that could impact its operations:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.